Key Takeaway: Telix has announced the release of its full year results and Australian Annual Report for the period ending December 31, 2024. The results will be disclosed on February 20, 2025, followed by an investor webcast and conference call on February 21, 2025. This event aims to provide insights to investors and stakeholders.
Price reaction · baseline $18.09 (2025-02-10 close) · hit after-hours · 4 other TLX headline(s) in the window, move may be shared
day 0 close · peak
-2.5%
Market Sentiment Analysis
POSITIVE FACTORS
Telix is set to release its full year results, indicating progress.
The investor webcast provides an opportunity for engagement.
The scheduled date shows transparency and planning.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+13%
120-day peak, hindsight
Typical move
7%
average across 7 past catalysts
Lead asset
131I-IPA
Phase 1 · Neoplastic Disease
Full Press Release Details
Melbourne (Australia) and Indianapolis, IN (U.S.A.) | 11 February 2025
Telix today advises that it will release its full year results and Australian Annual Report for the period ended 31 December 2024 on Thursday 20 February 2025.
An investor webcast and conference call will be held at 9.00am AEDT, Friday 21 February 2025 (5.00pm EST, Thursday 20 February 2025).